Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
Login | Create an Account
Upcoming | Past
 
Programs Date Hours
A FINANCIAL ANALYSIS OF HOW TO ESTABLISH A COMPARABLE FOR THE YEARS 2022, 2023, AND 2024 04/19/2024 1.50
IN ADDITION TO LOSING WEIGHT: DISCOVER THE SECRETS, BENEFITS AND RISKS OF SEMAGLUTIDE, TIRZEPATIDE AND LIRAGLUTIDE 04/14/2024 - 04/20/2024 2.00
THE LEADER THAT EVERYONE NEED 03/09/2024 3.00
COMMITED MEMBERS OF THE COLEGIO DE FARMACEUTICOS DE PR: EFFICIENCY, TRUSTWORTHINESS AND PROCEEDINGS 03/09/2024 2.50
PATIENT CENTERED APPROACH THAT FACILITATES ACCESS AND ADHERENCE TO MEDICATIONS 02/24/2024 1.50
STATISTICS AND A CONDUCTIVE METHOD FOR AUDITING YOURSELF BEFORE BEING FLAGGED BY A PBM 01/27/2024 3.00
CONDUCTIVE METHOD THAT CAN HELP US IN PBM COMPLIANCE 01/27/2024 3.00
USP 797 CHANGE IS HERE 01/27/2024 3.00
CYBERSECURITY IN THE ERA OF ARTIFICIAL INTELLIGENCE: CHALLENGES AND OPORTUNITIES 10/29/2023 1.00
WHAT SHOULD PHARMACISTS KNOW ABOUT OPTIMIZING CARE FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE AND VENOUS INSUFFICIENCY? 08/26/2023 2.00
UPDATE ON THE 2022 CDC CLINICAL PRACTICE GUIDELINE FOR PAIN MANAGEMENT 08/26/2023 2.00
HOW TO ESTABLISH A FINANCIAL ANALYSIS USING A PHARMACY COMPUTER SYSTEM 08/26/2023 - 10/10/2023 2.00
NONTRADITIONAL TREATMENTS: HOMEOPATHY AND HORMONE REPLACEMENT THERAPY 08/26/2023 2.00
PEARLS IN GERIATRIC CARE: FALL RISK PREVENTION AND SLEEP DISORDERS MANAGEMENT 08/26/2023 2.00
PUERTO RICO PHARMACY LAW REVIEW: OBLIGATIONS AND RIGHTS OF PHARMACISTS IN THE INSPECTION PROCESS 08/26/2023 3.00
FOUNDATION OF PHARMACY COMPOUNDING AND THE USP <795> AND <800> 08/26/2023 3.00
IMMUNIZATION UPDATES 2023 08/25/2023 2.00
DIFFICULT CONVERSATIONS: THE EFFECT OF COMMUNICATION SKILLS IN THE PATIENT-PHARMACIST RELATIONSHIP AND HOW TO MANAGE DIFFICULT SITUATION 08/25/2023 2.00
WHAT SHOULD I KNOW ABOUT THE 2022 AHA/ACC/HFSA HEART FAILURE MANAGEMENT GUIDELINES 08/25/2023 2.00
CYBERSECURITY THREATS IN THE PHARMACY SECTOR 08/25/2023 2.00
MEDICARE AND THE IRA REGULATIONS/ UNDERSTANDING HEALTHCARE PROVISIONS OF THE INFLATION REDUCTION ACT AND THE IMPACT ON HEALTHCARE ECOSYSTEM 08/25/2023 2.00
HIV PRE-EXPOSURE PROPHYLAXIS (PREP) CLINICAL UPDATES 08/25/2023 2.00
LABOR REFORM: WHAT IS THE IMPACT ON PHARMACY? 08/25/2023 2.00
ETHICAL CONSIDERATIONS WHILE REDUCING HEALTH DISPARITIES IN THE LGBTQ+ COMMUNITY 08/25/2023 3.00
UPDATES ON COPD MANAGEMENT: THE GOLD GUIDELINES 08/24/2023 2.00
IMPACT OF SOCIAL DETERMINANTS IN DIABETES MELLITUS PREVENTION AND MANAGEMENT: COMMUNITY AND AMBULATORY CARE APPROACH 08/24/2023 2.00
ACHIEVING A NORMAL WEIGHT: THE STRATEGIES AND PHARMACOTHERAPY THAT WILL HELP 08/24/2023 2.00
WORKING AND PRECEPTING A DIFFERENT GENERATION OF LEARNERS AND PRACTITIONERS 08/24/2023 2.50
BASIC COMMUNICATION IN AMERICAN SIGN LANGUAGE FOR PHARMACY 08/24/2023 2.00
NOVEL APPROACHES IN THE MANAGEMENT OF ALZHEIMER DISEASE: CONSIDERATIONS FOR PHARMACISTS AND PHARMACY TECHNICIANS 08/24/2023 2.00
BIOSIMILAR EXPANSION ERA: A REVIEW OF REGULATIONS AND DISPENSING ISSUES 08/24/2023 2.00
MEDICATION ERRORS 2023 08/24/2023 3.00
DRUG TRACE - PHARMACY REQUIREMENTS EFFECTIVE NOV 27, 2023 06/02/2023 3.00
HOW TO RUN YOUR PHARMACY 06/02/2023 2.00
NON – STERILE COMPOUNDING IN PEDIATRICS 05/04/2023 3.00
NON – STERILE COMPOUNDING FOR DERMATOLOGY 04/15/2023 3.00
NON-STERILE COMPOUNDING IN GASTROENTEROLOGY 03/11/2023 3.00
LEADERSHIP FOR THE PHARMACEUTICAL PROFESSIONAL 03/11/2023 3.00
MEDICATION SAFETY: A QUALITY AND RISK / FAILURE MANAGEMENT APPROACH 03/03/2023 2.00
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 3) 11/20/2022 6.00
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 2) 11/19/2022 6.00
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 1) 11/18/2022 6.00
HOW TO REDUCE PATIENT’S RISKS? PEARLS IN MEDICATION SAFETY 08/20/2022 2.00
UPDATE IN PHARMACY LAWS 08/20/2022 3.00
CLINICAL PEARLS: PHARMACISTS COMMITMENT IN ANTIMICROBIAL AND OPIOID STEWARDSHIP PROGRAMS 08/20/2022 2.00
OPTIMIZATION OF NON-OPIOIDS ANALGESICS: FROM THE THEORY TO THE PRACTICE 11/30/2020 1.50
 
Programs Release Date Expiration Date Hours
CYBERSECURITY IN THE ERA OF ARTIFICIAL INTELLIGENCE: CHALLENGES AND OPORTUNITIES 10/29/2023 12/13/2023 1.00
PUERTO RICO PHARMACY LAW REVIEW: OBLIGATIONS AND RIGHTS OF PHARMACISTS IN THE INSPECTION PROCESS ONLINE 08/26/2023 10/10/2023 3.00
ETHICAL CONSIDERATIONS WHILE REDUCING HEALTH DISPARITIES IN THE LGBTQ+ COMMUNITY - ONLINE 08/25/2023 10/09/2023 3.00
MEDICATION ERRORS 2023 - ONLINE 08/24/2023 10/09/2023 3.00
INFECTION CONTROL: NEW ERA CHALLENGES UPDATE 01/28/2022 01/28/2025 3.00
ENHANCING THE ROLE OF PHARMACIST IN THE MANAGEMENT 10/04/2021 10/04/2024 1.50
USP 800 HANDLING AND DISPOSAL HAZARD DRUGS VIDEO 11/08/2021 11/08/2024 2.00
PR STATE OPIOID RESPONSE AND PROGRAM VIDEO 12/10/2021 12/10/2024 2.00
LA CRISIS DE LOS OPIOIDES Y EL ROL DEL FARMACÉUTICO 07/07/2020 07/07/2023 1.50
MEDICATION ADHERENCE 11/04/2020 11/04/2023 1.50
COVID-19 IMMUNIZATION: WHAT PHARMACISTS SHOULD KNOW 12/30/2020 12/30/2023 2.00
EL MANEJO CLINICO DE HIPERTENSION 12/18/2020 12/18/2023 1.50
ANTIBIOTIC STEWARDSHIP STRATEGIES FOR DIVERSE PHARMACY SCENARIOS 05/25/2021 05/25/2024 1.50
PEDIATRICS COMPOUNDING PREPARATIONS 07/10/2021 07/10/2024 2.00
MEDICATION ERRORS 06/26/2021 06/26/2024 3.00
IMMUNIZATION UPDATED GUIDES 2021 09/01/2021 09/01/2024 1.50
COVID-19:ASPECTOS CLINICOS,DIAGNOSTICO Y TRATAMIEN 07/28/2020 07/28/2023 3.00
HIPERCOAGULABILIDAD Y EL COVID-19 09/28/2020 09/28/2023 2.50
MANIFESTACIONES NEUROPSIQUIÁTRICAS EN COVID-19 10/27/2020 10/27/2023 1.50
FRAUD AND DRUG ABUSE 11/15/2021 11/15/2024 4.00
OSHA: SAFETY AND DOCUMENTATION 11/15/2021 11/15/2024 2.00
BETTER BREATHING: UPDATES IN ASTHMA 02/23/2022 02/23/2025 2.00
ETHICAL ANALYSIS IN PHARMACY PRACTICE 02/23/2022 02/23/2025 3.00
LABORATORY TESTS, SUCH AS BEING ABLE TO USE THE INFORMATION TO PROVIDE BETTER PATIENT CARE 06/17/2022 11/23/2025 1.50
PHARMACY SCENARIOS AND ITS ETHICAL AND SOCIAL RESPONSIBILITY WITH RESPECT FOR DIVERSITY, EQUITY AND INCLUSION 07/06/2022 07/06/2025 1.50
PHARMACY SCENARIOS AND ITS ETHICAL AND SOCIAL RESPONSIBILITY: SUGGESTED STRATEGIES IN THE FACE OF HEALTH INEQUALITIES AND PROMOTING EQUITY AND INCLUSI 08/12/2022 08/12/2025 1.50
PHARMACY LAW: PART 1 IMPORTANT CONCERTS IN THE DEFINITIONS AND IDENTIFIED RESPONSIBILITIES 12/21/2022 12/25/2025 1.50
PHARMACY ACT PART 2: FUNCTIONS OF KEY PERSONNEL IN THE OPERATION OF A PHARMACY ESTABLISHMENT 03/24/2023 03/24/2026 1.50
FRAUD, DIVERSION AND SAFE CHAIN SUPPLY REFRESHER: WHAT IS NEW? 07/14/2023 07/14/2026 2.00
USP 800 REPHRESER - SAFE HANDLING OF HAZARDOUS DRUGS 07/14/2023 07/14/2026 2.00
VICTIMS OF MEDICATION ERRORS 12/13/2021 12/13/2024 1.50
INFECTIONS CONTROL: NEW ERA CHALLENGES 04/02/2020 04/02/2023 3.00
OPTIMIZING THE ROLE OF PHARMACIST IN THE MANAGEMENT OF DRY EYE 11/23/2021 11/23/2024 1.50
SAFE VACCINATION: BEST PRACTICES- PART 1 12/03/2021 12/03/2024 1.00
MEDICATION ERRORS CHALLENGES AND OPPORTUNITIES 10/08/2021 10/08/2024 1.50
PHARMACOGENOMICS PRINCIPLES 11/16/2023 11/16/2026 1.50
Colegio de Farmacéuticos de Puerto Rico | Teléfono:(787) 753-7157 | Dirección: PO Box 360206 San Juan, P.R. 00936-0206
Powered By: Learning ExpressCE
Copyright © 2024 Colegio de Farmacéuticos de PR. All Rights Reserved.
About Us Privacy Policy Terms of Service